Paul Janda, DO, JD

NPI: 1497924468
Total Payments
$17,809
2024 Payments
$2,620
Companies
71
Transactions
878
Medicare Patients
8,495
Medicare Billing
$1.4M

Payment Breakdown by Category

Food & Beverage$15,665 (88.0%)
Education$2,014 (11.3%)
Other$86.93 (0.5%)
Gifts$43.45 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $15,665 855 88.0%
Education $2,014 16 11.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $86.93 6 0.5%
Gift $43.45 1 0.2%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $3,172 145 $0 (2024)
Novartis Pharmaceuticals Corporation $1,483 99 $0 (2024)
Cadwell Industries, INC $1,185 3 $0 (2022)
Teva Pharmaceuticals USA, Inc. $1,113 43 $0 (2024)
EMD Serono, Inc. $933.19 44 $0 (2024)
UCB, Inc. $757.52 49 $0 (2024)
Genentech USA, Inc. $717.45 49 $0 (2024)
Biogen, Inc. $690.05 48 $0 (2024)
Allergan, Inc. $619.52 43 $0 (2022)
Amgen Inc. $519.09 32 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,620 115 ABBVIE INC. ($1,288)
2023 $3,021 144 ABBVIE INC. ($974.34)
2022 $3,825 161 Cadwell Industries, INC ($1,185)
2021 $1,473 55 Celgene Corporation ($319.22)
2020 $444.97 26 Novartis Pharmaceuticals Corporation ($98.31)
2019 $1,828 117 Allergan Inc. ($264.59)
2018 $2,071 124 Biogen, Inc. ($288.63)
2017 $2,525 136 Teva Pharmaceuticals USA, Inc. ($291.60)

All Payment Transactions

878 individual payment records from CMS Open Payments — Page 1 of 36

Date Company Product Nature Form Amount Type
12/20/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $0.84 General
Category: NEUROSCIENCE
12/18/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $10.51 General
Category: NEUROSCIENCE
12/16/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $32.73 General
Category: NEUROSCIENCE
12/10/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $23.69 General
Category: Neurology
12/10/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $8.86 General
Category: NEUROSCIENCE
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. HYQVIA (Biological) Food and Beverage In-kind items and services $22.03 General
Category: IMMUNOLOGY
12/03/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $32.60 General
Category: Rare Disease
11/19/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $26.33 General
Category: BOTOX THERAPEUTIC
11/18/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $11.49 General
Category: NEUROSCIENCE
11/07/2024 SK Life Science, Inc. XCOPRI (Drug) Food and Beverage In-kind items and services $19.28 General
Category: Neurology
11/06/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $23.20 General
Category: Neurology
11/05/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $24.85 General
Category: NEUROSCIENCE
11/05/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $15.80 General
Category: NEUROSCIENCE
10/30/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $27.09 General
Category: PAIN
10/29/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $6.53 General
Category: NEUROSCIENCE
10/22/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $26.77 General
Category: NEUROSCIENCE
10/21/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $20.69 General
Category: BOTOX THERAPEUTIC
10/21/2024 ARGENX US, INC. VYVGART (Drug) Food and Beverage In-kind items and services $16.71 General
Category: Immunology
10/15/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $16.79 General
Category: NEUROSCIENCE
10/15/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $1.43 General
Category: NEUROSCIENCE
10/09/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $25.54 General
Category: BOTOX THERAPEUTIC
10/07/2024 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $38.40 General
Category: EPILEPSY
10/07/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $24.64 General
Category: NEUROSCIENCE
10/02/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $23.63 General
Category: Neurology
10/02/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $0.09 General
Category: Neurology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 33 2,326 3,680 $1.5M $412,833
2022 26 2,019 3,328 $1.3M $353,391
2021 22 1,963 3,452 $1.1M $317,538
2020 21 2,187 4,409 $1.3M $365,430
Total Patients
8,495
Total Services
14,869
Medicare Billing
$1.4M
Procedure Codes
104

All Medicare Procedures & Services

104 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
95715 Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring Office 2023 45 131 $393,000 $84,671 21.5%
95816 Measurement of brain wave activity (eeg), awake and drowsy Office 2023 166 170 $157,590 $50,223 31.9%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2023 210 642 $150,870 $49,698 32.9%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 208 406 $127,890 $37,658 29.4%
95913 Nerve conduction, 13 or more studies Office 2023 115 115 $89,125 $25,879 29.0%
95923 Testing of autonomic (sympathetic) nervous system function Office 2023 163 173 $67,470 $16,662 24.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 110 113 $58,195 $14,209 24.4%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 58 244 $16,950 $11,747 69.3%
95911 Nerve conduction, 9-10 studies Office 2023 67 69 $41,745 $11,561 27.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 85 85 $35,573 $10,913 30.7%
95700 Measurement of brain wave activity (eeg), continuous Office 2023 49 50 $38,000 $10,268 27.0%
92546 Test for abnormal eye movement using a rotating chair Office 2023 94 94 $28,090 $9,323 33.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 78 89 $24,297 $8,948 36.8%
95724 Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional Office 2023 32 32 $32,064 $8,045 25.1%
92540 Evaluation and testing for balance with recording Office 2023 94 94 $24,675 $7,930 32.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 76 90 $18,180 $6,190 34.1%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2023 95 123 $18,450 $5,364 29.1%
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days Office 2023 28 128 $9,300 $5,037 54.2%
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes Office 2023 28 128 $9,110 $4,872 53.5%
95720 Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional Facility 2023 12 28 $18,312 $4,507 24.6%
95910 Nerve conduction, 7-8 studies Office 2023 29 29 $14,718 $3,994 27.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 39 63 $13,986 $3,873 27.7%
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 24 102 $7,650 $3,804 49.7%
93922 Ultrasound study of arm and leg arteries Office 2023 26 52 $29,640 $3,224 10.9%
92548 Test for balance and posture Office 2023 77 77 $19,250 $2,890 15.0%

About Paul Janda, DO, JD

Paul Janda, DO, JD is a Neurology healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1497924468.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Paul Janda, DO, JD has received a total of $17,809 in payments from pharmaceutical and medical device companies, with $2,620 received in 2024. These payments were reported across 878 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($15,665).

As a Medicare-enrolled provider, Janda has provided services to 8,495 Medicare beneficiaries, totaling 14,869 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Las Vegas, NV
  • Active Since 02/25/2008
  • Last Updated 02/13/2025
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1497924468

Products in Payments

  • BOTOX (Biological) $1,589
  • QULIPTA (Drug) $1,334
  • KESIMPTA (Drug) $925.11
  • UBRELVY (Drug) $520.80
  • TYSABRI (Biological) $518.29
  • Briviact (Drug) $477.79
  • Aimovig (Biological) $449.07
  • APTIOM (Drug) $442.46
  • OCREVUS (Biological) $423.76
  • ACTHAR (Biological) $414.58
  • ZEPOSIA (Drug) $384.56
  • NURTEC ODT (Drug) $332.76
  • AUSTEDO (Drug) $317.20
  • MAYZENT (Drug) $284.02
  • MAVENCLAD (Drug) $263.66
  • NUPLAZID (Drug) $262.12
  • LEMTRADA (Drug) $251.67
  • AUBAGIO (Drug) $250.87
  • Rebif (Biological) $250.59
  • UPLIZNA (Drug) $231.51

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Las Vegas